Corline Biomedical AB (STO:CLBIO)
Sweden · Delayed Price · Currency is SEK 13.75
+0.05 (0.36%)
Oct 13, 2026, 10:39 AM CET
Corline Biomedical AB Market Cap
Corline Biomedical AB has a market cap or net worth of 359.33 million as of October 12, 2026. It is the 32,929th most valuable company in the world and the 442nd biggest in Sweden. Its market cap has decreased by 22.78% in one year.
Market Cap
359.33M
Enterprise Value
331.26M
Revenue
12.39M
Global Rank
Country Rank
#442 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since June 3, 2015, Corline Biomedical AB's market cap has increased from 97.97M to 359.33M, an increase of 266.79%. That is a compound annual growth rate of 12.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 359.33M | 1.95% |
| Dec 30, 2025 | 352.45M | 86.79% |
| Dec 30, 2024 | 188.69M | -41.07% |
| Dec 29, 2023 | 320.21M | 61.61% |
| Dec 30, 2022 | 198.15M | -36.85% |
| Dec 30, 2021 | 313.77M | 25.86% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xspray Pharma AB | 527.27M |
| FluoGuide | 497.02M |
| Sprint Bioscience AB | 400.96M |
| Cantargia AB | 369.35M |
| Mendus AB | 352.13M |
| Intervacc AB | 303.32M |
| IRLAB Therapeutics AB | 259.95M |
| Xbrane Biopharma AB | 258.60M |